Large-scale testing (Phase 3)Study completedNCT01292239
What this trial is testing
A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients
Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 183